Struggling With Great Stock Picks? Discover StockInvest.us Top Gems!
Currently predicting for Fri, 10 May 2024

Trading levels for AGEN

Fibonacci Support & Resistance Levels

Level Price
Resistance R3 12.67 10.46 %
R2 12.23 6.60 %
R1 11.95 4.21 %
Current price: 11.47
Support S1 11.07 -3.51 %
S2 10.79 -5.90 %
S3 10.35 -9.76 %

Accumulated Volume Support & Resistance Levels

Level Price
Resistance R3 12.76 11.25 %
R2 12.01 4.71 %
R1 11.69 1.92 %
Current price 11.47
Support S1 0 .
S2 0 .
S3 0 .

AGEN Predictions History

6 years ago
Partha.Chris.1351 predicted that AGEN for 2018-03-06 is going $6.25 (4.34%)

Rank:

6 years ago
JS predicted that AGEN for 2018-02-21 is going $4.59 (-4.38%)

6 years ago
JS predicted that AGEN for 2017-07-21 is going $4.86 (-3.38%)

6 years ago
Andre.Toney.6967 predicted that AGEN for 2017-07-21 is going $3.10 (-38.37%)

Rank:

6 years ago
JuanC Villegas predicted that AGEN for 2017-07-12 is going $4.44 (2.07%)

6 years ago
JS predicted that AGEN for 2017-07-12 is going $4.29 (-1.38%)

6 years ago
henry predicted that AGEN for 2017-07-12 is going $4.44 (2.07%)

Rank:

6 years ago
GUY.REEVES.4800 predicted that AGEN for 2017-07-03 is going $4.01 (2.56%)

Rank:

7 years ago
GUY.REEVES.4800 predicted that AGEN for 2017-03-24 is going $4.01 (2.30%)

Rank:

7 years ago
JS predicted that AGEN for 2016-10-05 is going $7.30 (-0.82%)

Click to get the best stock tips daily for free!

About Agenus Inc.

Agenus. Agenus Inc., a clinical-stage immuno-oncology company, discovers and develops immuno-oncology products in the United States and internationally. The company offers Retrocyte Display, an antibody expression platform for the identification of fully human and humanized monoclonal antibodies; and display technologies. It develops vaccine programs comprising Prophage vaccine candidate; and QS-21 Stimulon adjuvant, a saponin-based vaccine adjuvant. The... AGEN Profile

Top Fintech Company

StockInvest.us featured in The Global Fintech Index 2020 as the top Fintech company of the country.

Full report by FINDEXABLE

ROCKIT